ctDNA Testing Is Poised to Reshape Risk Assessment and Treatment Decision-Making in Bladder Cancer - OncLive

ctDNA Testing Is Poised to Reshape Risk Assessment and Treatment Decision-Making in Bladder Cancer  OncLiveA urine test that could change the course of bladder cancer care  Medical XpressBladder Cancer: Urine Test Improves Relapse Predictions  Inside Precision MedicineUrinary Metabolites Identify Bladder Cancer and Predict Recurrence  European Medical JournalInnovative Urine Test Poised to Transform Bladder Cancer Treatment  Bioengineer.org